Indication
Multiple Sclerosis Relapse
2 clinical trials
2 products
1 drug
Clinical trial
Towards the Improvement of the Treatment of Acute Relapses in Multiple Sclerosis: A Randomized Double-blind, Non-inferiority Controlled Trial Comparing Intranasal Versus Intravenous MethylprednisoloneStatus: , Estimated PCD: 2024-11-27
Product
Nasal MethylprednisoloneClinical trial
A Randomized, Double-Blind, Delayed Treatment, Placebo-Controlled Trial to Assess the Changes in Multi-parametric MRI in MS Patients Taking Clemastine Fumarate as a Myelin Repair TherapyStatus: Recruiting, Estimated PCD: 2025-06-01
Product
ClemastineDrug
Varlilumab